Metoclopramide (Metoclopramide hydrochloride) is a gastrointestinal stimulant and antinauseant, prescribed for heartburn and esophagitis due to GERD and for treating patients who have gastroparesis ...
Metoclopramide is a generic prescription drug that’s used to treat gastroesophageal reflux and diabetic gastroparesis. Metoclopramide comes as oral tablets that might be taken only as needed, or every ...
RALEIGH, NC, September 8, 2009 - Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced the U.S. Food and Drug Administration (FDA) has granted marketing approval for METOZOLV TM ODT ...
Salix Pharmaceuticals has receiving marketing clearance for Metozolv (metoclopramide HCl) ODT (orally dissolving tablets) 5 mg and 10 mg orally disintegrating tablets for the relief of diabetic ...
The FDA has approved Metozolv ODT (metoclopramide HCl orally disintegrating tablets, from Salix) for short-term therapy (4–12 weeks) in adults with symptomatic, documented gastroesophageal reflux ...
Salix Pharmaceuticals, Ltd announced that Wilmington Pharmaceuticals received a complete response letter from the US Food and Drug Administration (FDA) for its New Drug Application (NDA) for Metozolv ...
Metoclopramide is a central dopamine D2-receptor antagonist used as an antiemetic and gastroprokinetic agent in dogs and cats 1,2,3,4. It has been used experimentally in pigeons as an antiemetic agent ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Metoclopramide Injection, USP in ...
Metoclopramide Injection 5mg/mL Prefilled Syringe by BD Rx Inc. Metoclopramide Injection, the second drug to be offered in the BD Simplist ready-to-administer line of prefilled generic injectables, ...
Metoclopramide (Metoclopramide Hcl) is a gastrointestinal stimulant and antinauseant, prescribed for heartburn and esophagitis due to GERD and for treating patients who have gastroparesis (partial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results